Infex Therapeutics Limited

Active09990238 Private limited company
Incorporated
5 February 2016 (10 years)
Previously known as
Amr Centre Limited (until 22 September 2020)
This list may be incomplete. See all names on Companies House
Industry
Research and experimental development on biotechnology (72110)
Accounts type
Small
Region
North West
Address
Mereside
Alderley Park
Macclesfield
SK10 4TG

Filing status

Accounts due
30 April 2028
Last accounts
31 July 2026
Conf. stmt due
13 February 2027
Last conf. stmt
30 January 2026

Charges

Total
3
Outstanding
1
Part satisfied
0
Satisfied
2

Officers 4 active

Officer details are public data from the Companies House register.

Director · Appointed 1 February 2023
Irish
Born July 1967 (59)
Director · Appointed 6 September 2016
British
Born March 1961 (65)
Director · Appointed 6 September 2016
British
Born October 1950 (76)
Director · Appointed 5 February 2016
British
Born February 1963 (63)
Officer history (6 former)
1 February 2023
Appointed Leonard, Colm, Professor as Director
12 May 2022
Resigned Flinn, Anthony, Dr as Director
11 August 2021
Resigned Mackay, Kathleen Phillippa, Dr as Director
18 May 2021
Resigned Stasiak, Pauline Christine, Dr as Director
18 October 2019
Appointed Mackay, Kathleen Phillippa, Dr as Director
29 March 2019
Resigned Yadi, Hakim Adam, Dr as Director
21 March 2019
Appointed Stasiak, Pauline Christine, Dr as Director
12 December 2017
Resigned Thorn, Simon William as Secretary
19 July 2017
Appointed Flinn, Anthony, Dr as Director
11 April 2017
Resigned Payne, Lloyd James, Dr as Director
6 September 2016
Appointed Payne, Lloyd James, Dr as Director
6 September 2016
Appointed Yadi, Hakim Adam, Dr as Director
6 September 2016
Appointed Moulton, Jonathan Paul as Director
6 September 2016
Appointed Doherty, Christopher as Director
5 February 2016
Appointed Jackson, Peter, Dr as Director
5 February 2016
Appointed Thorn, Simon William as Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Company Limited By Shares
Reg. no. 13917179
Former controllers (3)
6 April 2022
Ceased Catapult Life Sciences GP LLP — Owns 25–50% of shares
21 March 2019
Ceased Bruntwood Science Limited — Owns 25–50% of shares
19 July 2017
Ceased Moulton Goodies Limited — Owns 25–50% of shares

Financials

Cash
£97,124
Profit
£8,210,162
Employees
24
Current Ratio
0.3x

Trend

Shareholder Funds
(£15.0M) (£10.0M) (£5.0M) £0 £5.0M 2020 2021 2022 2024 2025 £235,520 £280,264 (£3,194,656) (£10,049,108) (£1,838,946)
Balance sheet detail
202520242023202220212020
Fixed Assets£4,440£2,475£30,954£27,940£15,624
Current Assets£767,399£1,029,219£711,479£3,429,592£974,425
Debtors£670,275£908,564£672,406£613,148£610,319
Cash£97,124£120,655£39,073£2,816,444£364,106
Creditors (< 1 year)£2,610,785£11,080,802£1,172,477£1,394,282£1,956,419£254,529
Creditors (> 1 year)£0£5,957,479£2,542,807£1,220,849£500,000
Net Current Assets(£1,843,386)(£10,051,583)(£682,803)£1,473,173£719,896
Net Assets(£10,049,108)(£3,194,656)£280,264£235,520
Shareholder Funds(£1,838,946)(£10,049,108)(£3,194,656)£280,264£235,520

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
4 November 2026Accounts for a small company31 July 2026
27 October 2026Registration of a charge

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?